Oramed Pharmaceuticals
ORMP
#9051
Rank
โ‚น11.36 B
Marketcap
โ‚น285.14
Share price
3.79%
Change (1 day)
36.59%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): -โ‚น10.71

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น11.77. In 2024 the company made an earnings per share (EPS) of -โ‚น43.45 a decrease over its 2023 EPS that were of โ‚น12.67.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น10.71-75.36%
2024-โ‚น43.45-442.86%
2023โ‚น12.67-114.89%
2022-โ‚น85.0920.51%
2021-โ‚น70.6139.29%
2020-โ‚น50.69-31.71%
2019-โ‚น74.23-4.65%
2018-โ‚น77.858.86%
2017-โ‚น71.51-9.2%
2016-โ‚น78.7529.85%
2015-โ‚น60.658.06%
2014-โ‚น56.125.08%
2013-โ‚น53.413.51%
2012-โ‚น51.60137.5%
2011-โ‚น21.72-60%
2010-โ‚น54.31-0%
2009-โ‚น54.31-16.67%
2008-โ‚น65.17-25%
2007-โ‚น86.90700%
2006-โ‚น10.86303.56%
2005-โ‚น2.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น537.69 4,469.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น318.04-2,802.65%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น335.44-2,950.53%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-โ‚น27.16 130.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-โ‚น17.20 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA